Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


AI model outperforms clinicians in diagnosing pediatric ear infections

Written by | 5 Sep 2022

An artificial-intelligence (AI) model built at Mass Eye and Ear was shown to be significantly more accurate than doctors at diagnosing pediatric ear infections in the first head-to-head… read more.

Pediatric kidney transplant patients fare better when kidney is from live donor

Written by | 18 Aug 2022

Do pediatric kidney transplant patients have better long-term outcomes when their kidney comes from living, biologically unrelated donors compared to deceased donors? A new UC Davis Health study finds that… read more.

Immunosuppressive drug’s blood level variability may identify pediatric kidney transplant recipients at risk of rejection

Written by | 2 Aug 2022

Although kidney transplantation is the most effective treatment for children with kidney failure, rejection of the transplanted organ by the recipient’s immune system is a major concern. Transplant… read more.

Pediatric liver disease increases risk of developing type 2 diabetes

Written by | 14 Jun 2022

Nonalcoholic fatty liver disease (NAFLD) is the most common pediatric liver disease, affecting 5 to 8 million children in the United States. In NAFLD, the cells of the… read more.

Opioid prescriptions for pediatric patients following surgical procedures have dropped significantly

Written by | 6 Apr 2022

Researchers from Children’s Hospital of Philadelphia (CHOP) and the University of Pennsylvania School of Medicine found that opioid prescriptions for children who underwent one of eight common outpatient surgeries declined over a… read more.

Nanoparticle-formulated drug combination is effective in medulloblastoma, a pediatric brain tumor

Written by | 28 Jan 2022

UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival… read more.

FDA approves expanded indication of Biktarvy for treatment of HIV-1 in pediatric populations – Gilead Sciences

Written by | 26 Oct 2021

Gilead Sciences, Inc. announced the FDA approved a new low-dose tablet dosage form of Biktarvy (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg tablets) for pediatric patients weighing… read more.

EU boost for vaccine production and paediatric use

Written by | 10 May 2021

Article written by Gary Finnegan. A flurry of activity at the European Medicines Agency (EMA) has provided a much-needed shot in the arm for European immunisation programmes. The… read more.

Five day treatment of pediatric pneumonia is as effective as longer treatment

Written by | 17 Mar 2021

Article by Bruce Sylvester. Treatment of common pneumonia in children six months to 10 years-old with a five-day course of high-dose amoxicillin is as effective as 10-day treatment,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.